CORD-19:e847d433e7424152a9846673209cb73027415ecd / 425855-426147 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T3908","span":{"begin":0,"end":292},"obj":"Sentence"},{"id":"T58216","span":{"begin":0,"end":292},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"CAP/CTM results were compared for quantification of HCV genotype 1-4 with those from a signal amplification assay based on the branched DNA (bDNA) technology, the Versant Quantitative 3.0 (Bayer Diagnostic, Tarrytown, NY, detection limit 615 IU/ml and dynamic range from 1185 to 1.5E7 IU/ml)."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T370","span":{"begin":0,"end":292},"obj":"Sentence"}],"text":"CAP/CTM results were compared for quantification of HCV genotype 1-4 with those from a signal amplification assay based on the branched DNA (bDNA) technology, the Versant Quantitative 3.0 (Bayer Diagnostic, Tarrytown, NY, detection limit 615 IU/ml and dynamic range from 1185 to 1.5E7 IU/ml)."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T1415","span":{"begin":242,"end":244},"obj":"Disease"},{"id":"T1416","span":{"begin":285,"end":287},"obj":"Disease"}],"attributes":[{"id":"A1415","pred":"mondo_id","subj":"T1415","obj":"http://purl.obolibrary.org/obo/MONDO_0006806"},{"id":"A1416","pred":"mondo_id","subj":"T1416","obj":"http://purl.obolibrary.org/obo/MONDO_0006806"}],"text":"CAP/CTM results were compared for quantification of HCV genotype 1-4 with those from a signal amplification assay based on the branched DNA (bDNA) technology, the Versant Quantitative 3.0 (Bayer Diagnostic, Tarrytown, NY, detection limit 615 IU/ml and dynamic range from 1185 to 1.5E7 IU/ml)."}